top of page
Founder Constance (Connie) Cullen, Ph.D., has over 20 years of experience in all aspects of drug development. She has successfully worked with both large Pharma and small biotech and understands the unique needs of each.
The firm has expertise in designing, developing, validating, and troubleshooting many analytical and bioanalytical assay formats, including those for purity, residuals, potency, biomarkers, anti-drug antibodies, and PK.
bottom of page